搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
TAG24 NEWS on MSN
3 小时
The winding, fitful path to the wildly popular weight loss drug Ozempic
Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...
Boise State Public Radio
7 小时
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
10 小时
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Barchart on MSN
11 小时
Snag This Biotech Stock Before November, Here's Why
As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...
13 小时
How Ozempic Works—and What’s Still a Mystery
Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...
devdiscourse
14 小时
Breaking Health News: Major Drug Approvals and Controversies
The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...
15 小时
Novo Nordisk's New Weight Loss Drug Shows Ominous Psychiatric Side Effects
Novo Nordisk, tje manufacturer behind Ozempic and Wegovy has another weight loss medication in the works — but according to ...
18 小时
Altimmune: Updated Data Supports Pemvidutide's 'Market Disruptor' Prospects
Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...
Mississippi Valley Publishing
21 小时
Fake obesity drugs are genuinely dangerous
We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...
BioPharma Dive
23 小时
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
1 天
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
1 天
Weight-loss meds get a markdown
Discounts of as much as half on the $1,000-plus-a-month injectables are meant to induce insurers to offer coverage to workers ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈